Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CPT-11 and 5-FU/LCV in Previously Untreated Gastric Adenocarcinoma
NCT00005607Phase 2Unknown
- Sponsor
- Robert H. Lurie Comprehensive Cancer Center
- Start
- Feb 2000
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of irinotecan, fluorouracil, folinic acid in gastric adenocarcinoma, gastroesophageal junction adenocarcinoma, sponsored by Robert H. Lurie Comprehensive Cancer Center. Status: unknown.
02
Drugs
irinotecanfluorouracilfolinic acid
03
Conditions
gastric adenocarcinomagastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on NCT00005607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005607.